Lv5
1180 积分 2022-08-08 加入
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
2天前
已完结
Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine
4天前
已完结
Glucagon-like peptide 1 in health and disease
4天前
已完结
Type 2 diabetes mellitus
4天前
已完结
Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal
4天前
已完结
Prevalence and Treatment of Diabetes in China, 2013-2018
4天前
已完结
Novel subgroups of patients with adult-onset diabetes in Chinese and US populations
6天前
已完结
Complete closure after colorectal endoscopic submucosal dissection with a re-openable clip with a sharp claw
9天前
已关闭
Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS
10天前
已完结
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes
14天前
已完结
皖公网安备34019202002308
